Summit Therapeutics Q3 2024 slides: Ivonescimab shows superior PFS vs. pembrolizumab

3 months ago 13
Read Entire Article
  1. Homepage
  2. Finance
  3. Summit Therapeutics Q3 2024 slides: Ivonescimab shows superior PFS vs. pembrolizumab

Related

Valereum nears completion of $200m royalty and streaming financing

Valereum nears completion of $200m royalty and streaming fin...

50 minutes ago 3
abrdn European Logistics Income to return €46.8 million to shareholders

abrdn European Logistics Income to return €46.8 million to s...

50 minutes ago 2
Earnings call transcript: Hafnia Q3 2025 earnings beat forecasts, stock dips

Earnings call transcript: Hafnia Q3 2025 earnings beat forec...

50 minutes ago 3

Trending

1. lina hidalgo
2. sasha digiulian
3. channel 13 news
4. forecast
5. spacex rocket launch
6. google
7. weather
8. whsv
9. wbal tv
10. hayley williams

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

10 months ago 619
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 486
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 347
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 305
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 303
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved